Evidence map›Paper›PMID 40819367›Full record

ArticleEpilepsia open2025

Epilepsy and systemic autoimmune diseases: A bidirectional two-sample Mendelian randomization study.

Ruoshi Tian, Wenlong Yu, Jiaqing Hu, Yan Yang, Xirui He

Abstract read
In one paragraph

Article in Epilepsia open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ruoshi TianSchool of Bioengineering, Zunyi Medical University, Zhuhai, China.
Wenlong YuSchool of Pharmacy, Zunyi Medical University, Zunyi, Guizhou, China.
Jiaqing HuSchool of Bioengineering, Zunyi Medical University, Zhuhai, China.
Yan YangSchool of Bioengineering, Zunyi Medical University, Zhuhai, China.
Xirui HeSchool of Bioengineering, Zunyi Medical University, Zhuhai, China.ORCID https://orcid.org/0000-0003-0287-3828

Funding

Academic New Seedling Cultivation and Innovation Exploration Project's Cultivation Project of Zunyi Medical University Qian Kehe Platform Talents (2018)5772-074, Qian Kehe Platform Talents (2019)-017Future 'Science and technology elite' project of Zunyi Medical University ZYSE-2024-01Guizhou Provincial Basic Research Program (Natural Science) Qian Kehe Foundation-ZK (2021) General-550National Natural Science Foundation of China 82260865Zhuhai Campus Technology Innovation Team of Zunyi Medical University ZHTD2024-3
6 · The paper itself

Abstract

objectiveEpidemiological data indicates that individuals with epilepsy exhibit an elevated susceptibility to autoimmune disorders, and conversely, those with systemic autoimmune diseases (SAD) demonstrate a heightened predisposition to epilepsy. Although an increasing number of publications support this association, the causal direction remains undetermined. This investigation offers evidence supporting a causal relationship between these conditions through a bidirectional two-sample Mendelian randomization (MR) analysis.

methodsBidirectional two-sample MR analyses were performed to investigate the causal relationships and directionality between various epilepsy subtypes and eight SAD. The analysis utilized genome-wide association study (GWAS) summary data for the following conditions: type 1 diabetes, systemic lupus erythematosus (SLE), inflammatory bowel disease (IBD), rheumatoid arthritis, coeliac disease, multiple sclerosis (MS), ulcerative colitis, and Crohn's disease.

resultsIn this study, causal analyses were performed for different epilepsy subtypes and SAD disorders. In the Inverse-Variance Weighted (IVW) model, the MR study indicated that focal epilepsy increased the risk of IBD [odds ratio (OR): 1.15, confidence interval (CI): 1.02-1.30, p: 0.027] and MS [OR: 1.25, CI: 1.07-1.47, p: 0.004]. Childhood absence epilepsy increased the risk of MS [OR: 0.25, CI: 0.07-0.90, p: 0.034]. Reverse analyses showed that SLE increased the risk of myoclonic epilepsy in adolescents [OR: 1.01, CI: 1.00-1.01, p: 0.042], and IBD [OR: 0.99, CI: 0.99-1.00, p: 0.013], and celiac disease [OR: 0.99, CI: 0.99-1.00, p: 0.021] reduced the risk of generalized epilepsy. The results demonstrated homogeneity, and the MR-Egger directions were concordant. SIGNIFICANCE: This study shows that epilepsy is a causal risk factor for both IBD and MS, providing new insights into the prevention of SAD in people with epilepsy. PLAIN LANGUAGE SUMMARY: This paper employs a bidirectional two-sample MR analysis to investigate the genetic correlation between epilepsy and autoimmune diseases, revealing potential associations between the onset of epilepsy and MS as well as IBD. Further exploration in this area requires support from clinical data.

Indexed as

Autoimmune DiseasesEpilepsyMendelian Randomization AnalysisCeliac DiseaseDiabetes Mellitus, Type 1Genetic Predisposition to DiseaseGenome-Wide Association StudyHumansLupus Erythematosus, SystemicMultiple Sclerosisbidirectional two‐sample Mendelian randomizationepilepsyGenosystemic autoimmune diseases

Identifiers

PMID40819367
PMCPMC12514391

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.